Dr. Perry Jansen, the health district’s medical director, gave the only presentation in favor of continuing to offer the COVID-19 vaccine. The health district serves more than 300,000 people in Canyon ...
NEW YORK — U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause ...
In a 15-0 vote, ACIP recommended that MenB-4C be administered as a two-dose series at 0 and 6 months when given to healthy ...
Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...
On Thursday, GSK plc (NYSE:GSK) revealed new preliminary data for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) in ...
STAT's Readout LOUD podcast discusses Pfizer's woes, explains RFK Jr.'s 'MAHA' campaign, and mulls the latest about the Novo ...
U.S. health officials are recommending that people 50 and older get a shot against bacteria that can cause pneumonia and ...
The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.
The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’s Prevnar 20 to 50 years down from 65.
The Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) is recommending that the age for pneumococcal vaccination be lowered from 65 to 50 years.
By Ava Gonzalez/UW News Lab Despite the current low totals of COVID-19 and flu cases, health officials are warning against complacency as Seattle approaches peak respiratory virus season and a 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback